About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Hrctm1.1Desa
targeted mutation 1.1, Despina Sanoudou
MGI:5911421
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Hrctm1.1Desa/Hrctm1.1Desa Not Specified MGI:5911422


Genotype
MGI:5911422
hm1
Allelic
Composition
Hrctm1.1Desa/Hrctm1.1Desa
Genetic
Background
Not Specified
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hrctm1.1Desa mutation (0 available); any Hrc mutation (43 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• about 25% of mice die by 6 months of age and about 50% die by 10 months

cardiovascular system
• left ventricular dimensions are moderately increased
• 3-4 month old mice show decreased fractional shortening and hearts ex vivo show reduced contraction
• rate of contraction (+dP/dt) is reduced by 25% in hearts
• cardiomyocytes exhibit decreased fractional shortening by 19% and rates of contraction are decreased by 16%
• rates of relaxation are decreased by 25% in cardiomyocytes
• rate of relaxation (-dP/dt) is reduced by 22% in hearts
• echocardiography shows decreased fractional shorting by 14%, left ventricular pressure reduced by 18%, moderately increased left ventricular dimensions, and slightly decreased intraventricular septum and posterior wall thickness in 3-4 month old mice
• 12 month old mice show a trend towards decreased fractional shortening and increased cardiac dimensions (left ventricular end systolic diameter and left ventricular end diastolic diameter)
• however, acute heart failure is not seen
• left ventricular pressure is reduced by 18%
• stress conditions induce episodes of ventricular tachycardia, including monomorphic and bidirectional ventricular tachycardia
• mice exhibit increased incidence of ventricular arrhythmias under stress conditions, with acute caffeine-epinephrine administration inducing complex forms of ventricular arrhythmias such as premature ventricular contractions clustered as couplets or bigeminy, and episodes of ventricular tachycardia, including monomorphic and bidirectional ventricular tachycardia
• treatment with KN-93, an inhibitor of CaMKII, reduces the occurrence of arrhythmic events, particularly life-threatening ones
• stress conditions induce premature ventricular contractions clustered as couplets or bigeminy
• cardiomyocytes exhibit increased occurrence of aftercontractions, calcium aftertransients, and triggered activity of spontaneous delayed afterdepolarizations
• under baseline conditions, cardiomyocytes show reduced contraction, calcium transients and sarcoplasmic reticulum calcium load
• cardiomyocytes exhibit increased total sarcoplasmic reticulum calcium leak by 58% and increased ratio of sarcoplasmic reticulum leak to sarcoplasmic reticulum calcium load by 68%, without an increase in calcium spark and wave frequency
• isoproterenol treatment increases contractility parameters, enhances the amplitude of calcium transients, shortens the rate of decay and increases the sarcoplasmic reticulum calcium load
• treatment of cardiomyocytes with KN-93 partly reduces the occurrence of spontaneous aftercontractions
• calcium wave propagation is slower, the duration of the associated sodium/calcium exchange current is increased and action potential duration is increased in cardiomyocytes indicating slower conduction and electrical remodeling of cardiomyocytes
• 71% of mice under acute catecholaminergic stress, induced by epinephrine and caffeine, develop complex premature ventricular contractions (bigeminy) and 57% develop ventricular tachycardia episodes indicating increased incidence of ventricular arrhythmias under stress

homeostasis/metabolism
• 71% of mice under acute catecholaminergic stress, induced by epinephrine and caffeine, develop complex premature ventricular contractions (bigeminy) and 57% develop ventricular tachycardia episodes indicating increased incidence of ventricular arrhythmias under stress

muscle
• 3-4 month old mice show decreased fractional shortening and hearts ex vivo show reduced contraction
• rate of contraction (+dP/dt) is reduced by 25% in hearts
• cardiomyocytes exhibit decreased fractional shortening by 19% and rates of contraction are decreased by 16%
• rates of relaxation are decreased by 25% in cardiomyocytes
• rate of relaxation (-dP/dt) is reduced by 22% in hearts





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/16/2024
MGI 6.23
The Jackson Laboratory